Sino Biopharmaceutical Ltd - Free Cash Flow To The Firm

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Free-Cash-Flow-To-The-Firm" stands at 11.22 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.

Sino Biopharmaceutical Ltd's second quarter result of 3.40 Billion HKD for the item "Free Cash Flow To The Firm" represents an increase of 60.21 percent compared to it's first quarter result.

Also, Sino Biopharmaceutical Ltd's second quarter result of 3.40 Billion HKD for the item "Free Cash Flow To The Firm" represents an increase of 127.34 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 11.22 Billion HKD for the item "Free Cash Flow To The Firm" represents an increase of 20.44 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 32.61 percent compared to the value the year prior.
The 1 year change in percent is 32.61.
The 3 year change in percent is 99.72.
The 5 year change in percent is 59.39.
The 10 year change in percent is 650.60.

The Serie's long term average value is 3.75 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 198.85 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2011, to it's latest available value, on 06/30/2025, is +1,622.82%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.